Últimas noticias sobre RMR Gr (NASDAQ:RMR) Bolsa

RMR Gr

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

RMR Group

The RMR Group Inc. - Class A Common Stock

The RMR Group Inc

RADISSON MINING RESOURCES by Radisson Mining Resources Inc.

Radisson Mining Resources Inc

RAND MERCHANT INVT HLDG by Rand Merchant Invt Hldgs Ltd.

OUTsurance Group Ltd

RMR INDUSTRIALS CL B by RMR Industrials, Inc.

Rocky Mountain Industrials Inc

Rimrock Gold Corp

RMRK

Armory Mining Corp

Baird analyst Eric Coldwell maintains Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) with a Neutral and raises the price target from $349 to $354.

News

Price Target

Analyst Ratings

MEDP

Baird Maintains Neutral on Medpace Hldgs, Raises Price Target to $354

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) rallied 17% over the past week, spurred by speculation around <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152684/musk-tweet-sparks-dogecoin-surge-fuels-speculation-on-x-payments">Elon Musk's X Payments platform</a> potentially incorporating DOGE.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.4254</td>
<td>$62.5 Billion</td>
<td>&nbsp;+2.3%</td>
<td>&nbsp;+17%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002593  </td>
<td>$15.3 Billion</td>
<td>+2.7%</td>
<td>&nbsp;+5.9%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.0000202</td>
<td>$8.5 Billion</td>
<td>+1.5%</td>
<td>&nbsp;-3.4%</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$98,129.53</td>
<td>$1.94 Trillion</td>
<td>+0.7%</td>
<td>+8.4%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Macro guru Raoul Pal highlighted that Dogecoin has outperformed Bitcoin by surging 550% since its launch, calling it &#8220;harder money&#8221; in this context and predicting potential continued outperformance.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">One of the most WILD things in all of crypto is that <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> has proven to be harder money than <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> and has outperformed by 550% since launch (10 years!) and looks like it might even to continue to outperform over time!&#x1f923; What a time to be alive&#8230; <a href="https://t.co/3EXQFEzPsb">pic.twitter.com/3EXQFEzPsb</a>
&mdash; Raoul Pal (@RaoulGMI) <a href="https://twitter.com/RaoulGMI/status/1860822834018181423?ref_src=twsrc%5Etfw">November 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Tardigrade expects DOGE to retrace to $0.30 before potentially spiking to $3, drawing <a href="https://x.com/TATrader_Alan/status/1860958108601966599">comparisons</a> to similar cycles from 2018-2021 and 2021-2025.
Crypto trader Master Kenobi sees a positive broader trend for DOGE but the timeline could shift, potentially influenced by changes in Bitcoin dominance. 
He added that the current market behavior resembles early January 2021 and if history repeats, volatility may follow, according to the trader. In the previous cycle, DOGE dropped 55% over two weeks, although such a drop isn&#8217;t guaranteed.
He <a href="https://x.com/btc_MasterPlan/status/1860790391332843921">suggests</a> a conservative target of $1 to $1.45 and noted that a green close this week would mark the second-longest streak of green weeks in DOGE's history (6 weeks, the record being 8 weeks in 2017-2018).
Statistics: IntoTheBlock data shows large transaction volume increasing by 41.1% and daily active addresses falling by 34.9%. 
Coinglass data shows liquidations at the lowest since Nov.2. Long liquidations stand at $3.74 million, short liquidations at $2.73 million. Open interest is at all time high levels of $3.95 billion.
Community News: Dogecoin spiked to $0.40 over the weekend after an Elon Musk tweet <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152684/musk-tweet-sparks-dogecoin-surge-fuels-speculation-on-x-payments">sparked speculations</a> about the forthcoming X Payments service, which could potentially support transactions with digital assets like DOGE.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152520/dogecoin-whales-move-214-5m-in-a-single-day-sparking-speculation">Dogecoin Whales Move $214.5M In A Single Day, Sparking Speculation</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$PEPE

$SHIB

Dogecoin Is 'Harder Money' Than Bitcoin, Says Raoul Pal: Here's What The Numbers Say

WIIM

PLTR

Palantir Technologies shares are trading higher after Wedbush maintained an Outperform rating on the stock and raised its price target from $57 to $75.

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Gain Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GANX#NASDAQ">GANX</a>) with a Buy and maintains $8 price target.

Reiteration

GANX

HC Wainwright & Co. Reiterates Buy on Gain Therapeutics, Maintains $8 Price Target

D. Boral Capital analyst Jesse Sobelson maintains EON Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EONR#AMEX">EONR</a>) with a Buy and lowers the price target from $6 to $4.5.

EONR

D. Boral Capital Maintains Buy on EON Resources, Lowers Price Target to $4.5

Baird analyst Justin Kleber maintains Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) with a Outperform and raises the price target from $35 to $40.

CHWY

Baird Maintains Outperform on Chewy, Raises Price Target to $40

CGTX

Cognition Therapeutics shares are trading higher after the company provided an update on a biomarker analysis from the Phase 2 SHINE study in mild-to-moderate Alzheimer's disease.

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) with a Buy and maintains $15 price target.

ABEO

HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $15 Price Target

Northland Capital Markets analyst Ted Jackson downgrades Xos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOS#NASDAQ">XOS</a>) from Outperform to Market Perform and lowers the price target from $9 to $5.

Downgrades

Northland Capital Markets Downgrades Xos to Market Perform, Lowers Price Target to $5

WestPark Capital analyst Paul Rodriguez reiterates CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Hold.

CRWD

WestPark Capital Reiterates Hold on CrowdStrike Holdings

Rosenblatt analyst Barton Crockett maintains Quad/Graphics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QUAD#NYSE">QUAD</a>) with a Buy and raises the price target from $7.7 to $10.3.

QUAD

Rosenblatt Maintains Buy on Quad/Graphics, Raises Price Target to $10.3

"Alarum's fourth quarter 2024 revenues are estimated at $7.5 million ±3% and Adjusted EBITDA for the fourth quarter 2024 is expected to range from $1.3 million to $1.7 million."

Guidance

ALAR

Alarum Technologies Expects Q4 Revenue Of $7.5M ±3% Vs $7.48M Est

HC Wainwright &amp; Co. analyst Mitchell Kapoor maintains CARISMA Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARM#NASDAQ">CARM</a>) with a Buy and lowers the price target from $8 to $5.

CARM

HC Wainwright & Co. Maintains Buy on CARISMA Therapeutics, Lowers Price Target to $5

ELAB

Elevai Labs shares are trading lower after the company announced a 1-for-200 reverse stock split.

SNOW

Snowflake shares are trading higher after Wedbush upgraded the stock from Neutral to Outperform.

UXIN

Uxin shares are trading higher after the company reported Q2 sales of $70.85 million, up from $48.80 million year-over-year.

Macy's shares are trading lower after the company delayed its Q3 earnings release and conference call, citing an issue related to delivery expenses in one of its accrual accounts, prompting an independent investigation.

BBWI

Bath & Body Works shares are trading higher after the company reported better-than-expected Q3 EPS and sales and raised its 2024 guidance.

Rosenblatt analyst Catharine Trebnick maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and raises the price target from $325 to $385.

Rosenblatt Maintains Buy on CrowdStrike Holdings, Raises Price Target to $385

The study is evaluating the safety, tolerability, efficacy, pharmacokinetics, and biomarkers of orally administered PL8177 in adult patients with active ulcerative colitis.

Biotech

Health Care

General

Palatin Technologies Has Completed Enrollment In Its Phase 2 Study Of PL8177 For Ulcerative Colitis, The Last Patient Visit Is Expected To Occur In Q1 Of 2025, With Topline Data Expected Shortly Thereafter

RMR Group declares $0.45 dividend

REITs Rally As Earnings Begin

ADT Non-GAAP EPS of $0.20 beats by $0.03, revenue of $1.2B misses by $20M

RMR Group Q4 2024 Earnings Preview

Here are the major earnings after the close today

RMR Group Non-GAAP EPS of $0.51 beats by $0.13, revenue of $212.3M misses by $8.05M

Reports Q4 revenue $212.3M, two estimates $220.35M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

RMR Group reports Q4 adjusted EPS 34c, consensus 38c

In a report released today, Tyler Batory from Oppenheimer maintained a Hold rating on The RMR Group (RMR – Research Report). The company's shares c...

Oppenheimer Keeps Their Hold Rating on The RMR Group (RMR)

The RMR Group Inc. (RMR) Q4 2024 Earnings Call Transcript

JMP Securities analyst Mitchell Germain maintained a Hold rating on The RMR Group (RMR – Research Report) today. The company's shares closed yester...

JMP Securities Remains a Hold on The RMR Group (RMR)

AGNC

AGNCL

AGNCM

AGNCN

AGNCO

AGNCP

ANGI

AROC

ASRT

ATER

BLDG

BXMT

CCAP

CHCT

CUBE

DHCNI

DHCNL

EQIX

FREL

GATO

GQRE

GRAB

HAUS

HAUZ

HOMZ

HRTX

IFGL

ILPT

INDS

INVH

IRET

KBWY

LAZR

MORT

NAIL

NETL

NURE

OPINL

PFFR

PINE

PLDGP

PPTY

QUIK

RDOG

REET

REGCO

REGCP

REIT

REXR

RIET

RIOCF

ROOF

SBAC

SBRA

SCHH

SRVR

STWD

STXS

TALO

USRT

VIOO

VRAI

WELL

XLRE

YALA

ZETA

Press Releases

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares

Seven Hills Realty Trust Announces Quarterly Dividend on Common Shares

Seven Hills Realty Trust Announces Third Quarter 2024 Results

The RMR Group Reschedules Fiscal Fourth Quarter 2024 Conference Call to Tuesday, November 12th

Comments

RMR Gr

Noticias

Últimas noticias sobre RMR Gr (NASDAQ:RMR) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL